It's no secret there's an organ shortage in the United States and elsewhere throughout the world.
Each day, 79 people on average receive organ transplants in the U.S. At the same time, 22 people on average die waiting for a transplant, …
Tivorsan Pharmaceuticals Inc. has received orphan drug designation from the U.S. Food and Drug Administration for a drug used in the treatment of Duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle degeneration and weakness.
Kelly Nevins is the first full-time executive director of MedMates, Rhode Island’s health care technology network group. She spoke recently with PBN about its short- and long-term goals and her role with the organization.
By Susan Decker and Christopher Yasiejko Bloomberg News